大型机构药物基因组学实施项目对患者医疗照护感知的影响
该前瞻性研究分析了参与机构药物基因组学实施项目的患者-医生配对,通过患者调查评估信任/隐私/共情/医疗决策/个性化照护维度。2012-2015年间向507名患者发放1261份问卷,回收792份(62.8%)。结果显示医生考虑药物基因组学结果后,隐私、共情、医疗决策和个性化照护评分显著更高;当医生利用药物基因组信息指导用药调整时,个性化照护评分显著高于无基因组指导的处方访视(4.0 vs 3.0,P<0.001),多变量模型证实基因组影响处方后的个性化照护评分更优(OR=3.26,95%CI 1.31-8.14,P<0.05)。
要点
- 医生考虑药物基因组学结果后,患者隐私、共情、医疗决策和个性化照护评分显著更高。
- 利用药物基因组信息指导用药调整时,个性化照护评分显著高于无基因组指导的处方访视(4.0 vs 3.0,P<0.001)。
- 多变量模型证实基因组影响处方后的个性化照护评分更优(OR=3.26,95%CI 1.31-8.14,P<0.05)。
核心结论
- 医生利用药物基因组学结果时似乎实现了个性化照护,且这种决策增强被患者积极感知。
研究设计与样本
- 前瞻性研究,分析参与机构药物基因组学实施项目的患者-医生配对。
- 2012-2015年间向507名患者发放1261份问卷,回收792份(62.8%)。
- 通过患者调查评估信任、隐私、共情、医疗决策和个性化照护维度(Likert量表1-5分)。
主要发现
- 医生考虑药物基因组学结果后,隐私、共情、医疗决策和个性化照护评分显著更高。
- 医生利用药物基因组信息指导用药调整时,个性化照护评分显著高于无基因组指导的处方访视(4.0[1.4] vs 3.0[1.6],P<0.001)。
- 多变量模型控制临床因素后,基因组影响处方后的个性化照护评分更优(OR=3.26,95%CI 1.31-8.14,P<0.05)。
临床怎么用
- 临床药师在用药调整中整合药物基因组学结果,可能提升患者对个性化照护的感知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite growing clinical use of genomic information, patient perceptions of genomic-based care are poorly understood. We prospectively studied patient-physician pairs who participated in an institutional pharmacogenomic implementation program. Trust/privacy/empathy/medical decision-making (MDM)/personalized care dimensions were assessed through patient surveys after clinic visits at which physicians had access to preemptive pharmacogenomic results (Likert scale, 1 = minimum/5 = maximum; mean [SD]). From 2012-2015, 1,261 surveys were issued to 507 patients, with 792 (62.8%) returned. Privacy, empathy, MDM, and personalized care scores were significantly higher after visits when physicians considered pharmacogenomic results. Importantly, personalized care scores were significantly higher after physicians used pharmacogenomic information to guide medication changes (4.0 [1.4] vs. 3.0 [1.6]; P < 0.001) compared with prescribing visits without genomic guidance. Multivariable modeling controlling for clinical factors confirmed personalized care scores were more favorable after visits with genomic-influenced prescribing (odds ratio [OR] = 3.26; 95% confidence interval [CI] = (1.31-8.14); P < 0.05). Physicians seem to individualize care when utilizing pharmacogenomic results and this decision-making augmentation is perceived positively by patients.
引用
- McKillip RP, Borden BA, Galecki P, et al. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017. PMID: 27981566. doi:10.1002/cpt.586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。